Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Galaxy $1.3 billion exchangeable senior notes offering
We advised Galaxy on the offering
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
Versant Media Group $1 billion senior secured notes offering
We advised the Comcast unit on the offering, which is being made in conjunction with Comcast’s planned spinoff of Versant
Qorvo $22 billion combination with Skyworks Solutions
We are advising Qorvo on the transaction
ADC Therapeutics $60 million private placement
We advised ADC Therapeutics on the transaction involving its common shares and pre-funded warrants
CSX $300 million senior notes reopening
We advised CSX on the investment-grade debt offering
Morgan Stanley $8 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Galaxy $460 million strategic investment
We advised Galaxy on the equity offering
Albertsons $750 million accelerated share repurchase
We advised Albertsons on the transaction